These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 33359485)

  • 1. Causes, effects, and clinical implications of perturbed patterns within the cancer epigenome.
    Oleksiewicz U; Machnik M
    Semin Cancer Biol; 2022 Aug; 83():15-35. PubMed ID: 33359485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas mediated epigenome editing for cancer therapy.
    Ansari I; Chaturvedi A; Chitkara D; Singh S
    Semin Cancer Biol; 2022 Aug; 83():570-583. PubMed ID: 33421620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic markers and therapeutic targets for metastasis.
    Kravitz CJ; Yan Q; Nguyen DX
    Cancer Metastasis Rev; 2023 Jun; 42(2):427-443. PubMed ID: 37286865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaco-epigenomics: On the Road of Translation Medicine.
    López-Camarillo C; Gallardo-Rincón D; Álvarez-Sánchez ME; Marchat LA
    Adv Exp Med Biol; 2019; 1168():31-42. PubMed ID: 31713163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic biomarkers in aging and longevity: Current and future application.
    Izadi M; Sadri N; Abdi A; Serajian S; Jalalei D; Tahmasebi S
    Life Sci; 2024 Aug; 351():122842. PubMed ID: 38879158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rebelled epigenome: histone H3S10 phosphorylation and H3S10 kinases in cancer biology and therapy.
    Komar D; Juszczynski P
    Clin Epigenetics; 2020 Oct; 12(1):147. PubMed ID: 33054831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetics in prostate cancer: biologic and clinical relevance.
    Jerónimo C; Bastian PJ; Bjartell A; Carbone GM; Catto JW; Clark SJ; Henrique R; Nelson WG; Shariat SF
    Eur Urol; 2011 Oct; 60(4):753-66. PubMed ID: 21719191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondria signaling to the epigenome: A novel role for an old organelle.
    Santos JH
    Free Radic Biol Med; 2021 Jul; 170():59-69. PubMed ID: 33271282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of cancer-specific epigenomic changes in biofluids: powerful tools in biomarker discovery and application.
    Nogueira da Costa A; Herceg Z
    Mol Oncol; 2012 Dec; 6(6):704-15. PubMed ID: 22925902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic Viruses and the Epigenome: How Viruses Hijack Epigenetic Mechanisms to Drive Cancer.
    MacLennan SA; Marra MA
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conservation of Aging and Cancer Epigenetic Signatures across Human and Mouse.
    Pérez RF; Tejedor JR; Santamarina-Ojeda P; Martínez VL; Urdinguio RG; Villamañán L; Candiota AP; Sarró NMV; Barradas M; Fernandez-Marcos PJ; Serrano M; Fernández AF; Fraga MF
    Mol Biol Evol; 2021 Jul; 38(8):3415-3435. PubMed ID: 33871658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translational epigenetics: clinical approaches to epigenome therapeutics for cancer.
    Selcuklu SD; Spillane C
    Epigenetics; 2008; 3(2):107-12. PubMed ID: 18437050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenome Remodeling in Cholangiocarcinoma.
    O'Rourke CJ; Lafuente-Barquero J; Andersen JB
    Trends Cancer; 2019 Jun; 5(6):335-350. PubMed ID: 31208696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenome engineering in cancer: fairytale or a realistic path to the clinic?
    Falahi F; Sgro A; Blancafort P
    Front Oncol; 2015; 5():22. PubMed ID: 25705610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities.
    Ge T; Gu X; Jia R; Ge S; Chai P; Zhuang A; Fan X
    Cancer Commun (Lond); 2022 Nov; 42(11):1049-1082. PubMed ID: 36266736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linking epidemiology to epigenomics--where are we today?
    Ulrich CM; Grady WM
    Cancer Prev Res (Phila); 2010 Dec; 3(12):1505-8. PubMed ID: 21149325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the epigenome with bioactive food components for cancer prevention.
    Ong TP; Moreno FS; Ross SA
    J Nutrigenet Nutrigenomics; 2011; 4(5):275-92. PubMed ID: 22353664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenome-metabolism nexus in the retina: implications for aging and disease.
    Mondal AK; Gaur M; Advani J; Swaroop A
    Trends Genet; 2024 Aug; 40(8):718-729. PubMed ID: 38782642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precise epigenomic editing with a SunTag-based modular epigenetic toolkit.
    Guhathakurta S; Adams L; Jeong I; Sivakumar A; Cha M; Bernardo Fiadeiro M; Hu HN; Kim YS
    Epigenetics; 2022 Dec; 17(13):2075-2081. PubMed ID: 35920441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenomic Characterization of Lymphoid Neoplasms.
    Duran-Ferrer M; Martín-Subero JI
    Annu Rev Pathol; 2024 Jan; 19():371-396. PubMed ID: 37832942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.